These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10858324)

  • 1. Mass spectrometric measurement of formaldehyde generated in breast cancer cells upon treatment with anthracycline antitumor drugs.
    Kato S; Burke PJ; Fenick DJ; Taatjes DJ; Bierbaum VM; Koch TH
    Chem Res Toxicol; 2000 Jun; 13(6):509-16. PubMed ID: 10858324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear targeting and nuclear retention of anthracycline-formaldehyde conjugates implicates DNA covalent bonding in the cytotoxic mechanism of anthracyclines.
    Taatjes DJ; Fenick DJ; Koch TH
    Chem Res Toxicol; 1999 Jul; 12(7):588-96. PubMed ID: 10409398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth inhibition, nuclear uptake, and retention of anthracycline-formaldehyde conjugates in prostate cancer cells relative to clinical anthracyclines.
    Taatjes DJ; Koch TH
    Anticancer Res; 1999; 19(2A):1201-8. PubMed ID: 10368676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doxorubicin-formaldehyde conjugate, doxoform: induction of apoptosis relative to doxorubicin.
    Burke PJ; Koch TH
    Anticancer Res; 2001; 21(4A):2753-60. PubMed ID: 11724351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidoxoform: a hydrolytically more stable anthracycline-formaldehyde conjugate toxic to resistant tumor cells.
    Taatjes DJ; Fenick DJ; Koch TH
    J Med Chem; 1998 Apr; 41(8):1306-14. PubMed ID: 9548820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doxoform and Daunoform: anthracycline-formaldehyde conjugates toxic to resistant tumor cells.
    Fenick DJ; Taatjes DJ; Koch TH
    J Med Chem; 1997 Aug; 40(16):2452-61. PubMed ID: 9258351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of epidoxorubicin-formaldehyde virtual crosslink of DNA and evidence for its formation in human breast-cancer cells.
    Podell ER; Harrington DJ; Taatjes DJ; Koch TH
    Acta Crystallogr D Biol Crystallogr; 1999 Sep; 55(Pt 9):1516-23. PubMed ID: 10489446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous incorporations of two anticancer drugs into DNA. The structures of formaldehyde-cross-linked adducts of daunorubicin-d(CG(araC)GCG) and doxorubicin-d(CA(araC)GTG) complexes at high resolution.
    Zhang H; Gao YG; van der Marel GA; van Boom JH; Wang AH
    J Biol Chem; 1993 May; 268(14):10095-101. PubMed ID: 8486678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical ionization mass spectrometric determination of acrolein in human breast cancer cells.
    Kato S; Post GC; Bierbaum VM; Koch TH
    Anal Biochem; 2002 Jun; 305(2):251-9. PubMed ID: 12054454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear targeting and retention of anthracycline antitumor drugs in sensitive and resistant tumor cells.
    Taatjes DJ; Koch TH
    Curr Med Chem; 2001 Jan; 8(1):15-29. PubMed ID: 11172689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiestrogen binding site and estrogen receptor mediate uptake and distribution of 4-hydroxytamoxifen-targeted doxorubicin-formaldehyde conjugate in breast cancer cells.
    Burke PJ; Kalet BT; Koch TH
    J Med Chem; 2004 Dec; 47(26):6509-18. PubMed ID: 15588086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formaldehyde in human cancer cells: detection by preconcentration-chemical ionization mass spectrometry.
    Kato S; Burke PJ; Koch TH; Bierbaum VM
    Anal Chem; 2001 Jul; 73(13):2992-7. PubMed ID: 11467545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alkylation of DNA by the anthracycline, antitumor drugs adriamycin and daunomycin.
    Taatjes DJ; Gaudiano G; Resing K; Koch TH
    J Med Chem; 1996 Oct; 39(21):4135-8. PubMed ID: 8863788
    [No Abstract]   [Full Text] [Related]  

  • 14. Modulatory effect of tamoxifen and ICI 182,780 on adriamycin resistance in MCF-7 human breast-cancer cells.
    De Vincenzo R; Scambia G; Benedetti Panici P; Fattorossi A; Bonanno G; Ferlini C; Isola G; Pernisco S; Mancuso S
    Int J Cancer; 1996 Nov; 68(3):340-8. PubMed ID: 8903476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Among substituted 9,10-dihydro-9,10-[1,2]benzenoanthracene-1,4,5,8-tetraones, the lead antitumor triptycene bisquinone TT24 blocks nucleoside transport, induces apoptotic DNA fragmentation and decreases the viability of L1210 leukemic cells in the nanomolar range of daunorubicin in vitro.
    Perchellet EM; Sperfslage BJ; Wang Y; Huang X; Tamura M; Hua DH; Perchellet JP
    Anticancer Drugs; 2002 Jul; 13(6):567-81. PubMed ID: 12172502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schisandrin A reverses doxorubicin-resistant human breast cancer cell line by the inhibition of P65 and Stat3 phosphorylation.
    Zhang ZL; Jiang QC; Wang SR
    Breast Cancer; 2018 Mar; 25(2):233-242. PubMed ID: 29181822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomics reveals protein profile changes in doxorubicin--treated MCF-7 human breast cancer cells.
    Chen ST; Pan TL; Tsai YC; Huang CM
    Cancer Lett; 2002 Jul; 181(1):95-107. PubMed ID: 12430184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of glutathione conjugation to adriamycin in human breast cancer MCF-7/DOX cells. Inhibition of glutathione S-transferase p1-1 by glutathione conjugates from anthracyclines.
    Gaudiano G; Koch TH; Lo Bello M; Nuccetelli M; Ravagnan G; Serafino A; Sinibaldi-Vallebona P
    Biochem Pharmacol; 2000 Dec; 60(12):1915-23. PubMed ID: 11108808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoic acid-derived cross-linked liposomes for reduction-responsive delivery of anticancer drug.
    Ling L; Ismail M; Du Y; Yao C; Li X
    Int J Pharm; 2019 Apr; 560():246-260. PubMed ID: 30769133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of anthracyclinic antibiotics with cytoskeletal components of cultured carcinoma cells (CG5).
    Molinari A; Calcabrini A; Crateri P; Arancia G
    Exp Mol Pathol; 1990 Aug; 53(1):11-33. PubMed ID: 2209808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.